Hair Loss/Baldness

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Hair Loss/Baldness trials you may qualify for

100

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 26 trials

RecruitingPhase 1/2

NCT07317544

Study of ABS-201 Evaluating Single and Multiple Ascending Doses in Healthy Adults With and Without Androgenetic Alopecia

The goal of this clinical trial is to learn if ABS-201 (a new medication) is safe and tolerable when used to improve hair growth in men and women. The trial wil…

Australia227 participantsStarted 2025-12-03

Treatment: ABS-201 IV Single Dose, Placebo IV

RecruitingNot Applicable

NCT04764357

Study Of Cold Cap Therapy For Prevention of Hairloss in Pediatric Patients Receiving Chemotherapy For Non-Malignant Indi…

This study is being done to see if the Paxman scalp cooling device can prevent hair loss in pediatric patients receiving chemotherapy for non-cancerous conditio…

United States40 participantsStarted 2021-06-04

Treatment: Paxman Scalp Cooling System, Alopecia Assessments

RecruitingPhase 2

NCT07533006

A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)

The purpose of this study is to evaluate how well LY4005130 works in participants with severe alopecia areata (hair loss) when compared with placebo, and how we…

United States60 participantsStarted 2026-04-14

Treatment: LY4005130, Placebo

RecruitingNot Applicable

NCT07502976

Topical 2-Deoxy-D-ribose Hydrogel Versus Minoxidil 5% Solution for Androgenetic Alopecia

Androgenetic alopecia is a common form of hair loss that can affect quality of life. This randomized controlled trial aims to evaluate the efficacy and safety o…

Egypt60 participantsStarted 2026-01-01

Treatment: Topical 2-Deoxy-D-ribose Hydrogel, Topical Minoxidil 5% Solution

RecruitingPhase 4

NCT04207931

Treatment Results for Patients With Central Centrifugal Cicatricial Alopecia (CCCA): a Multicenter Prospective Study

The objective of this study is to examine photos of CCCA patients taken before and after treatment to compare treatment outcomes between different treatment gro…

United States250 participantsStarted 2018-04-30

Treatment: Topical steroid class I-II, Triamcinolone Acetonide

RecruitingNot Applicable

NCT07484061

Efficacy and Safety of a Drinkable Nutraceutical for Hair Loss in Patients Using GLP-1/GIP Receptor Agonists

The purpose of this clinical trial is to evaluate the efficacy of Olistic© Next Women, a nutraceutical supplement, compared with placebo in improving hair loss…

Spain40 participantsStarted 2026-03-16

Treatment: Drinkable multifactorial food supplement containing vitamins, minerals, amino acids, plant extracts, and other bioactive compounds, formulated to support hair growth and scalp health in women +45., Placebo control

All recent trials (100 shown)

Active — Not RecruitingPhase 2

NCT06018428

A Phase 2a Proof-of-Concept Trial of Bempikibart (ADX-914) for the Treatment of Severe Alopecia Areata (SIGNAL-AA)

Part A is a randomized, double-blind, placebo-controlled, multi-center Proof-of-Concept (POC) Trial in subjects with severe Alopecia Areata. All participants in…

United States75 participantsStarted 2023-09-12

Treatment: bempikibart (ADX-914)

CompletedNot Applicable

NCT07348120

Efficacy and Safety of Millet Seed Extract in Telogen Effluvium Treatment

This is a randomized, double-blind, controlled clinical trial investigating the efficacy and safety of millet seed extract capsules in treating telogen effluviu…

Egypt60 participantsStarted 2025-05-01

Treatment: Millet Seed Extract group, Biotin group

Hair Loss/Baldness

Trial phase breakdown

Trial status

Actively recruiting — 26 trials

Study of ABS-201 Evaluating Single and Multiple Ascending Doses in Healthy Adults With and Without Androgenetic Alopecia

Study Of Cold Cap Therapy For Prevention of Hairloss in Pediatric Patients Receiving Chemotherapy For Non-Malignant Indi…

A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)

Topical 2-Deoxy-D-ribose Hydrogel Versus Minoxidil 5% Solution for Androgenetic Alopecia

Treatment Results for Patients With Central Centrifugal Cicatricial Alopecia (CCCA): a Multicenter Prospective Study

Efficacy and Safety of a Drinkable Nutraceutical for Hair Loss in Patients Using GLP-1/GIP Receptor Agonists

All recent trials (100 shown)

A Phase 2a Proof-of-Concept Trial of Bempikibart (ADX-914) for the Treatment of Severe Alopecia Areata (SIGNAL-AA)

Efficacy and Safety of Millet Seed Extract in Telogen Effluvium Treatment

Trial phase breakdown

Trial status

Actively recruiting — 26 trials

Study of ABS-201 Evaluating Single and Multiple Ascending Doses in Healthy Adults With and Without Androgenetic Alopecia

Study Of Cold Cap Therapy For Prevention of Hairloss in Pediatric Patients Receiving Chemotherapy For Non-Malignant Indi…

A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)

Topical 2-Deoxy-D-ribose Hydrogel Versus Minoxidil 5% Solution for Androgenetic Alopecia

Treatment Results for Patients With Central Centrifugal Cicatricial Alopecia (CCCA): a Multicenter Prospective Study

Efficacy and Safety of a Drinkable Nutraceutical for Hair Loss in Patients Using GLP-1/GIP Receptor Agonists

All recent trials (100 shown)

A Phase 2a Proof-of-Concept Trial of Bempikibart (ADX-914) for the Treatment of Severe Alopecia Areata (SIGNAL-AA)

Efficacy and Safety of Millet Seed Extract in Telogen Effluvium Treatment

Evaluation of the Performance of a Nutricosmetic on Hair & Scalp in Women and Men After 3 and 6 Months

Penguin Cold Caps in the Prevention of Hair Loss in Breast Cancer Patients

Natural History and Pathogenesis of Alopecia in Children and Adults

Portable Scalp Cooling System (PSCS) to Prevent Hair Loss for Breast Cancer Patients (Cooler Heads)

VENEZE Peptide Factor Hair Serum Compared With Topical 2% Minoxidil for Androgenetic Alopecia

Phase 3 Study to Evaluate the Efficacy and Safety of Oral Minoxidil (N1087) in Men With Androgenetic Alopecia.

Clinical Study of DA-001 as a Treatment for Hair Shedding Reduction and Hair Re-Growth

Long-Term PF-06651600 for the Treatment of Alopecia Areata

Efficacy and Tolerability of a Scalp Serum

Association of Serum VEGF-A and VCAM-1 Levels With Nailfold Capilleroscopic Alterations in Alopecia Areata

Study to Evaluate Xtresse Serum in Individuals With Thinning Hair

Harnessing Artificial Intelligence for Diagnosing Androgenetic Alopecia: A Training and Validation Study

XVIE to Treat Androgenetic Alopecia (AGA)

A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss

SCALp Cooling for pReventing aLopecia With nEw anTibody-drug Conjugates

Topical Methotrexate vs Minoxidil for Localized Alopecia Areata

Clinical Trial to Evaluate CG2001 in Chinese Adult Male Participants With Androgenetic Alopecia

Clinical Study to Evaluate Effect of Shampoo in Subjects With Hair Loss.